Details for 2012152282

Up to date per 04.04.2026

Actions

Title / Product Name

Verfahren zur Dosierung eines oral aktiven 1,2,4-Oxadiazols für Therapien zur Unterdrückung von Nonsense-Mutationen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012152282

EP Publication Number

2460520

E-Number

751979

Language

PCT Number

Publication Date

06.06.2012 A

30.09.2015 B1

Registration Date

30.09.2015

AT Publication Date

15.10.2015

Application Date

11.10.2007

Registration Number

Priorities

12.10.2006

851450 P

IPC

A61K 31/4245 20060101AFI20120503BHEP

Maximum Duration of Protection

11.10.2027

Owner

PTC Therapeutics, Inc.100 Corporate Court, Middlesex Business Center South Plainfield, NJ 07080US

Representative

No representatives present

Inventor

Hirawat, Samit5 Buxton Road Chatham, New Jersey 07928US

Miller, Langdon3057 Perkins Lane West Seattle, Washington 98199US